Name: BIOSYENT INC (RX) Stock
Brand: BIOSYENT INC
Rating: 8 (3 reviews)

RX.CA Latest News, Press Relases and Analysis

All

Press Releases

2 months ago - By: BioSyent Inc.

BioSyent Releases Financial Results for Q2 and H1 2025

2 months ago - By: BioSyent Inc.

BioSyent Declares Third Quarter 2025 Dividend

2 months ago - By: BioSyent Inc.

BioSyent Schedules Q2 and H1 2025 Earnings Release for August 21, 2025

6 months ago - By: BioSyent Inc.

BioSyent Releases Financial Results for First Quarter 2025

6 months ago - By: BioSyent Inc.

BioSyent Declares Second Quarter 2025 Dividend

6 months ago - By: BioSyent Inc.

BioSyent Schedules First Quarter Earnings Release for May 15, 2025

2 years ago - By: BioSyent Inc.

BioSyent Named to 2024 TSX Venture 50

2 years ago - By: BioSyent Inc.

BioSyent Announces the Availability of Gelclair® in Canada

6 months ago - By: BioSyent Inc.

BioSyent to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference

7 months ago - By: BioSyent Inc.

BioSyent to Attend Planet MicroCap Showcase

7 months ago - By: BioSyent Inc.

FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Tenth Consecutive Year

7 months ago - By: BioSyent Inc.

FeraMAXᴹᴰ est la marque de supplément de fer que les pharmaciens et les médecins au Canada recommandent le plus souvent depuis dix années consécutives

7 months ago - By: BioSyent Inc.

BioSyent Announces Grant of Restricted Share Units

8 months ago - By: BioSyent Inc.

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2024

8 months ago - By: BioSyent Inc.

BioSyent Schedules Fourth Quarter and Full Year 2024 Earnings Release for March 13, 2025

9 months ago - By: BioSyent Inc.

BioSyent Declares First Quarter 2025 Dividend

11 months ago - By: BioSyent Inc.

BioSyent Announces Renewal of Normal Course Issuer Bid

a year ago - By: BioSyent Inc.

BioSyent Releases Financial Results for Q3 and YTD 2024

a year ago - By: BioSyent Inc.

BioSyent Declares Fourth Quarter 2024 Dividend

a year ago - By: BioSyent Inc.

BioSyent Schedules Q3 and YTD 2024 Earnings Release for November 20, 2024

a year ago - By: BioSyent Inc.

BioSyent Announces Agreement to Purchase Tibelia® (tibolone) Assets

a year ago - By: BioSyent Inc.

BioSyent Releases Financial Results for Q2 and H1 2024

a year ago - By: BioSyent Inc.

BioSyent Declares Third Quarter 2024 Dividend

a year ago - By: BioSyent Inc.

BioSyent In-Licenses Endocrinology Product for Canada

a year ago - By: BioSyent Inc.

BioSyent Releases Financial Results for Q1 2024

a year ago - By: BioSyent Inc.

BioSyent Declares Second Quarter 2024 Dividend

a year ago - By: BioSyent Inc.

BioSyent Schedules Q1 2024 Earnings Release for May 16, 2024

2 years ago - By: BioSyent Inc.

BioSyent to Attend Planet MicroCap Showcase

2 years ago - By: BioSyent Inc.

BioSyent Announces Extension of RepaGyn® and Proktis-M® Agreement

2 years ago - By: BioSyent Inc.

BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference

2 years ago - By: BioSyent Inc.

BioSyent to Present at LD Micro New York Investor Conference

2 years ago - By: BioSyent Inc.

BioSyent Announces Grant of Restricted Share Units

2 years ago - By: BioSyent Inc.

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2023

2 years ago - By: BioSyent Inc.

BioSyent Schedules Fourth Quarter and Full Year 2023 Earnings Release for March 13, 2024

2 years ago - By: BioSyent Inc.

BioSyent Declares First Quarter 2024 Dividend

2 years ago - By: BioSyent Inc.

BioSyent Announces Renewal of Normal Course Issuer Bid

2 years ago - By: BioSyent Inc.

BioSyent Releases Q3 and YTD 2023 Financial Results

2 years ago - By: BioSyent Inc.

BioSyent Declares Fourth Quarter 2023 Dividend

2 years ago - By: BioSyent Inc.

BioSyent Launches "menopauseinformation.ca" on World Menopause Day

2 years ago - By: BioSyent Inc.

BIOSYENT INC (RX.CA) Stock News

RX.CA Latest News, Press Relases and Analysis